Předmět: |
|
Zdroj: |
Medical Devices & Surgical Technology Week; 2/19/2023, p1874-1874, 1p |
Abstrakt: |
Keywords: Cancer; Diagnostics and Screening; Endocrine System Diseases and Conditions; Endocrinology; Genetics; Health and Medicine; Hyperparathyroidism; Nervous System Diseases and Conditions; Neurocutaneous Syndromes; Neurodegenerative Diseases and Conditions; Neurofibromatoses; Neurofibromatosis; Neurofibromatosis Type 1; Neuromuscular Diseases and Conditions; Oncology; Parathyroid Diseases and Conditions; Peripheral Nervous System Diseases and Conditions; Pheochromocytoma; Primary Hyperparathyroidism EN Cancer Diagnostics and Screening Endocrine System Diseases and Conditions Endocrinology Genetics Health and Medicine Hyperparathyroidism Nervous System Diseases and Conditions Neurocutaneous Syndromes Neurodegenerative Diseases and Conditions Neurofibromatoses Neurofibromatosis Neurofibromatosis Type 1 Neuromuscular Diseases and Conditions Oncology Parathyroid Diseases and Conditions Peripheral Nervous System Diseases and Conditions Pheochromocytoma Primary Hyperparathyroidism 2023 FEB 17 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Current study results on neurofibromatosis type 1 have been published. According to the news editors, the research concluded: "The development of primary hyperparathyroidism in these two cases of pheochromocytomas associated with genetically confirmed NF-1 raises the possibility that primary hyperparathyroidism may develop in patients with NF-1-associated pheochromocytoma.". [Extracted from the article] |
Databáze: |
Complementary Index |
Externí odkaz: |
|